[HTML][HTML] Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease

DR Ashby, DP Gale, M Busbridge, KG Murphy… - Kidney international, 2009 - Elsevier
Hepcidin is a critical inhibitor of iron export from macrophages, enterocytes, and
hepatocytes. Given that it is filtered and degraded by the kidney, its elevated levels in renal …

[HTML][HTML] Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin

DR Ashby, DP Gale, M Busbridge, KG Murphy… - …, 2010 - ncbi.nlm.nih.gov
Expression of hepcidin, the key hormone governing iron transport, is reduced by anemia in a
manner which appears dependent on increased bone marrow activity. The temporal …

[HTML][HTML] Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment

DR Ashby, HE Ford, KJ Wynne, AM Wren, KG Murphy… - Kidney international, 2009 - Elsevier
Malnutrition is a common complication in patients on dialysis and is strongly associated with
poor prognosis. Effective therapy could substantially improve morbidity and mortality, but …

Bacteremia associated with tunneled hemodialysis catheters: outcome after attempted salvage

DR Ashby, A Power, S Singh, P Choi… - Clinical Journal of the …, 2009 - journals.lww.com
Background and objectives: Treatment without catheter replacement (catheter salvage) has
been described for bacteremia associated with tunneled venous catheters in hemodialysis …

Renal transplantation after removal and prevention of resynthesis of HLA antibodies

DH Taube, JS Cameron, CS Ogg, KI Welsh… - The Lancet, 1984 - Elsevier
Plasma exchange and immunosuppression with prednisolone and cyclophosphamide were
used to remove HLA antibodies and prevent their resynthesis in five patients awaiting renal …

Xenografts—future prospects for clinical transplantation

TDH Cairns, DH Taube, N Stevens, R Binns, KI Welsh - Immunology letters, 1991 - Elsevier
This paper outlines the basic problems that still need to be overcome before xenografting
becomes a reality. It presents evidence that if the first of these problems (preformed or …

Blood cyclosporin concentrations and renal allograft dysfunction.

DW Holt, JT Marsden, A Johnston, M Bewick… - Br Med J (Clin Res …, 1986 - bmj.com
Forty nine renal allograft recipients taking oral cyclosporin suffered 76 episodes of renal
dysfunction within six months of transplantation. These episodes were diagnosed as graft …

Successful treatment of middle aged and elderly patients with end stage renal disease.

DH Taube, EA Winder, CS Ogg, M Bewick… - Br Med J (Clin Res …, 1983 - bmj.com
Many patients over the age of 55 with end stage renal disease in the United Kingdom are
denied dialysis or transplantation. Although the reasons are complex, anticipation of a poor …

Differentiation between allograft rejection and cyclosporin nephrotoxicity in renal-transplant recipients

DH Taube, DG Williams, B Hartley, CJ Rudge… - The Lancet, 1985 - Elsevier
In a retrospective study of 60 renal-transplant patients immunosuppressed with cyclosporin
no specific clinical features differentiated allograft dysfunction responsive to anti-rejection …

Morphological differentiation between rejection and cyclosporin nephrotoxicity in renal allografts.

GH Neild, DH Taube, RB Hartley, L Bignardi… - Journal of clinical …, 1986 - jcp.bmj.com
In a prospective study of renal dysfunction in 60 consecutive allograft recipients treated with
cyclosporin and prednisolone routine renal biopsies at one week and one month after …